Healthcare entity
Sentiment skews more negative than the wider beat, at 40% negative against 26% across all 632 Healthcare stories in the same window. That works out to roughly 0.3 stories per week across a 133-day span. At 6.2, the average consequence score sits above the same-window beat average of 6.1.
Last mentioned: Jul 15, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 40 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Sentiment skews more negative than the wider beat, at 40% negative against 26% across all 632 Healthcare stories in the same window. That works out to roughly 0.3 stories per week across a 133-day span. At 6.2, the average consequence score sits above the same-window beat average of 6.1. Of the tracked stories, 1 of 5 also mention Abbott Laboratories, the most common co-covered peer. Source depth averages 4.2 original sources per story, versus 3.8 across the same-window beat baseline. market-trends accounts for 2 of the 5 tracked stories, while 2 other categories carry the remainder. This profile follows 5 Healthcare stories mentioning Roche across the period from March 5, 2026 to July 15, 2026.
Computed from the 5 stories linked to this entity, with beat comparisons drawn from all 632 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Roche. Shared-story counts are live from our verified record — not editorial picks.
79th World Health Assembly
Target deadline for the conclusion of negotiations on a legally binding global pandemic agreement.
Trial Failure Announced
Roche confirms the oral SERD candidate failed to meet primary endpoints; shares dip immediately.
Roche Africa Press Day
Policymakers and scientists meet in Kenya to discuss the transition of labs from emergency assets to essential infrastructure.
Phase II Data Review
Earlier data had suggested potential efficacy, leading to high investor expectations for the Phase III results.
78th World Health Assembly
Adoption of the global pandemic preparedness resolution and initial framework for the PABS system.
Combination Trials Launch
Roche expanded the program to include combination therapies with CDK4/6 inhibitors.
Two of Australia’s most used MS therapies, Ocrevus and Kesimpta, face a PBS pricing review that could slash subsidies by 40–50%. Without coverage, patients could pay over $33,000 annually, jeopardizing treatment access for thousands.
As global diabetes prevalence reaches record highs, the shift toward localized medical device production is driving a surge in glucometer manufacturing plant investments for 2026. This briefing analyzes the cost structures, regulatory hurdles, and technological requirements for establishing high-volume diagnostic production facilities.
Source: openpr.com · openpr.com
FUJIFILM Biotechnologies has appointed industry veteran Christiane Bardroff as its new Chief Business Officer to lead global commercial strategy. The move comes as the CDMO giant continues a multi-billion dollar expansion of its manufacturing footprint across Europe and North America.
Source: finanznachrichten.de · pharmiweb.com
Roche's stock fell on March 9, 2026, following the failure of its oral breast cancer candidate in a key clinical trial. This setback complicates the Swiss pharmaceutical giant's efforts to modernize its oncology portfolio and compete in the lucrative oral SERD market.
Source: northweststar.com.au · hardenexpress.com.au
African health leaders and Roche are advocating for a fundamental shift in how laboratory systems are funded and integrated into national health frameworks. The move aims to replace 'emergency-only' funding with sustainable infrastructure to ensure pandemic preparedness and equitable access to diagnostics.
Source: Ghana Newss (gh) · Emefa A. Ewoenam Atiamoah Eli 01pm (gh)
Roche is linked from 5 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
